A detailed history of Raymond James Financial Inc transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 20,100 shares of SENS stock, worth $125,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,100
Previous 21,600 6.94%
Holding current value
$125,826
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$0.43 - $0.58 $645 - $869
-1,500 Reduced 6.94%
20,100 $8,000
Q2 2025

Aug 14, 2025

SELL
$0.48 - $0.77 $480 - $770
-1,000 Reduced 4.42%
21,600 $10,000
Q1 2025

May 13, 2025

SELL
$0.43 - $1.31 $11,309 - $34,453
-26,300 Reduced 53.78%
22,600 $14,000
Q4 2024

Feb 06, 2025

BUY
$0.25 - $0.59 $12,225 - $28,851
48,900 New
48,900 $25,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $2.91B
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.